Market Challenges And Opportunities
Global Artificial Intelligence in Oncology Market Drivers:
- Advancement in AI and Machine Learning technologies: With the substantial advancement in technologies such as artificial intelligence, machine learning, deep learning, and computer vision, it has opened up new possibilities for their application in the field of oncology as well. Advanced algorithms that can learn from huge volumes of cancer treatment-related data are being developed, which can help in performing precision diagnosis, predicting disease progression, and giving an accurate prognosis. These algorithms have the potential to outperform human experts by identifying subtle patterns and correlations in medical imaging, genetic data, and other types of patient information.
- Support for Clinical Decision Making: Another key driver for the adoption of AI in oncology is its potential to empower clinicians to make well-informed treatment decisions. AI-based clinical decision support systems that can recommend optimized therapy regimens by learning from the outcomes of a large number of past cancer patients are becoming more common. These systems mine databases containing records of thousands of patients treated historically and use statistical modeling to suggest personalized treatment plans for new patients. The recommendations generated take into account individual patient attributes, genomic profile of the tumor, responses to previous lines of therapy and several other factors. Such decision-support tools are helping oncologists choose right drugs, drug combinations, and sequencing of therapies.
Global Artificial Intelligence in Oncology Market Restraints:
- Lack of awareness of AI applications in healthcare: The most significant hurdle to deep learning techniques is the management of massive datasets and databases, as well as the training and knowledge of AI systems as well as machine learning. However, the use of AI may result in data infringements because it may provide critical individual data like genomic sequences.
- Shortage of trained healthcare professionals: The shortage of trained healthcare professionals is significantly restraining the growth of artificial intelligence in oncology market. Oncology is a specialized field that requires extensive medical training to properly diagnose and treat cancer patients. However, there is a growing shortage of oncologists and other cancer care providers across the globe to meet the rising patient demand. This shortage of trained oncology staff impacts the development and adoption of AI technologies in cancer care. For AI solutions to be effectively utilized, domain experts are needed to develop advanced algorithms by providing large annotated medical imaging and genetic datasets. Healthcare providers also need to have a certain level of technical expertise to integrate and leverage AI tools in clinical decision making. But the existing crunch in oncology workforce restricts the resources and manpower available to support these AI-related initiatives.
Global Artificial Intelligence in Oncology Market Opportunities:
- The increasing prevalence of cancer: The increasing prevalence of cancer around the world poses opportunities for advancing patient care through innovative technologies. This projected surge in cancer burden challenges the capabilities and resources of existing healthcare infrastructures. At the same time, this serves as a strong driver for the development of advanced tools that can help in the prevention, early detection, and effective treatment of cancer. Artificial intelligence is emerging as one of the most promising technologies that can massively help in oncology. AI systems have the potential to analyze huge volumes of complex patient data, like genomic information, medical images, and clinical records, far better than humans. This enables more precise cancer screening and diagnostics, individualized treatment selection, and critical research discoveries. For example, AI algorithms are being trained on large databases of medical scans to identify subtle clues that human experts may miss, helping detect tumors at earlier stages. For instance, according to the World Health Organization (WHO), in February 2022, cancer was a leading cause of death worldwide, accounting for nearly 10 million deaths globally in 2020.
- The increasing healthcare expenditure: Increasing healthcare expenditure is expected to create opportunities for the global artificial intelligence in oncology market. As countries around the world allocate more resources to their healthcare systems, this financial influx helps to improve healthcare infrastructure, expand the availability of medical services, and increase access to advanced medical technologies, including AI. This is expected to create future growth opportunity for the market
U.S.: 
U.K. : 
India : 